European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

By M. Baccarani, M. Deininger, G. Rosti, Andreas Hochhaus, S. Soverini, J. Apperley, F. Cervantes, R. Clark, J. Cortes, F. Guilhot and 22 more. Blood, 2013

1,917 citations recorded by the source corpus.

Subfields: Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/f78edb5722c7e44aed2f96ed89712737feffe661

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Arber
2. R. Hasserjian
3. A. Orazi
4. M. Cazzola
5. J. Vardiman
6. J. Thiele
7. M. Borowitz
8. M. L. Le Beau

Citations in the corpus

• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. (2016, positive): “In the era of tyrosine-kinase inhibitor (TKI) therapy, newly diagnosed patients may have a nearly normal lifespan, but regular monitoring for BCR-ABL1 burden and for evidence of genetic evolution anddevelopment of resistance toTKI therapy is essential to detect disease progression.(3,4)Although the ”